| Dr Ashwini K Gupta, MD | |
|
405 Arrowhead Blvd, Jonesboro, GA 30236-1254 | |
| (770) 478-9877 | |
| (770) 478-2908 |
| Full Name | Dr Ashwini K Gupta |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 47 Years |
| Location | 405 Arrowhead Blvd, Jonesboro, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467443218 | NPI | - | NPPES |
| 00307744E | Medicaid | GA | |
| 050030319 | Other | GA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 025981 (Georgia) | Primary |
| 208VP0000X | Pain Medicine - Pain Medicine | 025981 (Georgia) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emory Specialty Associates, Llc | 3476559782 | 430 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
| Entity Name | Capitol Anesthesiology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245287192 PECOS PAC ID: 5799774642 Enrollment ID: O20040507000216 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
| Entity Name | Ams Southeast Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487107157 PECOS PAC ID: 3870880792 Enrollment ID: O20160921000551 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
| Entity Name | Premier Anesthesia Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811403207 PECOS PAC ID: 6608123724 Enrollment ID: O20180720001402 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
| Entity Name | Dpi Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407323199 PECOS PAC ID: 0941546923 Enrollment ID: O20190111001990 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
| Entity Name | Radius Anesthesia Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861996225 PECOS PAC ID: 2567897127 Enrollment ID: O20200109000552 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashwini K Gupta, MD 236 Montrose Dr, Mcdonough, GA 30253-4242 Ph: (770) 389-9852 | Dr Ashwini K Gupta, MD 405 Arrowhead Blvd, Jonesboro, GA 30236-1254 Ph: (770) 478-9877 |
News Archive
Two of humanity's biggest problems - the climate crisis and abysmal eating habits - can partly be solved by one healthy solution: eating more food from trees, specifically tropical ones.
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
The total cost for treating a child with autism can reach $5 million, but insurance companies rarely cover autism therapy and few states mandate it. CBS News reports that "an estimated one in every 150 children in America has autism and the number of reported cases is growing" while "parents are increasingly demanding that insurance companies cover the newest treatment."
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
› Verified 8 days ago
Dr. Francis K. Acquah, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 405 Arrowhead Blvd, Suite C, Jonesboro, GA 30236 Phone: 770-478-9877 | |
Dr. Anita C. Tolentino, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 405 Arrowhead Blvd, Suite C, Jonesboro, GA 30236 Phone: 770-478-9877 | |
Dr. James L. Alexander, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 405 Arrowhead Blvd, Suite C, Jonesboro, GA 30236 Phone: 770-478-9877 | |
Dr. Arturo Lorenzo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 405 Arrowhead Blvd, Jonesboro, GA 30236 Phone: 770-478-9877 Fax: 770-478-2908 | |
Hee C Jung, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 405 Arrowhead Blvd, Suite C, Jonesboro, GA 30236 Phone: 770-478-9877 | |
Mrs. Victoria A. Sneed, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 405 Arrowhead Blvd, Jonesboro, GA 30236 Phone: 770-478-9877 |